Related references
Note: Only part of the references are listed.Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
Hugo Marcel Johan Vanderstichele et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies
Olivier Bousiges et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cerebrospinal Fluid Biomarkers in Alzheimer's and Parkinson's Diseases-From Pathophysiology to Clinical Practice
Kaj Blennow et al.
MOVEMENT DISORDERS (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability
Anthony Fourier et al.
CLINICA CHIMICA ACTA (2015)
Importance and Impact of Preanalytical Variables on Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
Nathalie Le Bastard et al.
CLINICAL CHEMISTRY (2015)
A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Sun Ah Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2015)
Chasing the effects of pre-analytical confounders - a multicenter study on CSF-AD biomarkers
Maria Joao Leitao et al.
FRONTIERS IN NEUROLOGY (2015)
Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
Aline Dorey et al.
Frontiers in Neurology (2015)
Impact of harmonization of collection tubes on Alzheimer's disease diagnosis
Sylvain Lehmann et al.
ALZHEIMERS & DEMENTIA (2014)
Amyloid-beta 42 adsorption following serial tube transfer
Jamie Toombs et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Identification of an important potential confound in CSF AD studies: aliquot volume
Jamie Toombs et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
Magdalena Nutu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
Hugo Vanderstichele et al.
ALZHEIMERS & DEMENTIA (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimer's Disease from Non-Alzheimer's Dementia
P. E. Spies et al.
CURRENT ALZHEIMER RESEARCH (2010)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
N. A. Verwey et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho-Tau in patients with low- and high-CSF Aβ40 load
Jens Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Prediction of Alzheimer's disease using the CSF A beta 42/A beta 40 ratio in patients with mild cognitive impairment
Oskar Hansson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides
P Lewczuk et al.
CLINICAL CHEMISTRY (2006)
Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ42 peptide relative to Aβ40
W Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Kinetics of protein adsorption and desorption on surfaces with grafted polymers
F Fang et al.
BIOPHYSICAL JOURNAL (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk et al.
NEUROBIOLOGY OF AGING (2004)
Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides
M Bibl et al.
ELECTROPHORESIS (2004)
The molecular bases of Alzheimer's disease and other neurodegenerative disorders
RB Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2001)